<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.2.280">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>Geriatrics Evidence Synthesis - Evidence Tables</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1.6em;
  vertical-align: middle;
}
</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "navbar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "end",
  "type": "overlay",
  "limit": 20,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit"
  }
}</script>


<link rel="stylesheet" href="styles.css">
</head>

<body class="nav-fixed">


<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
    <nav class="navbar navbar-expand-lg navbar-dark ">
      <div class="navbar-container container-fluid">
      <div class="navbar-brand-container">
    <a class="navbar-brand" href="./index.html">
    <span class="navbar-title">Geriatrics Evidence Synthesis</span>
    </a>
  </div>
          <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarCollapse" aria-controls="navbarCollapse" aria-expanded="false" aria-label="Toggle navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
  <span class="navbar-toggler-icon"></span>
</button>
          <div class="collapse navbar-collapse" id="navbarCollapse">
            <ul class="navbar-nav navbar-nav-scroll me-auto">
  <li class="nav-item">
    <a class="nav-link" href="./index.html">
 <span class="menu-text">Home</span></a>
  </li>  
  <li class="nav-item dropdown ">
    <a class="nav-link dropdown-toggle" href="#" id="nav-menu-preop" role="button" data-bs-toggle="dropdown" aria-expanded="false">
 <span class="menu-text">Preop</span>
    </a>
    <ul class="dropdown-menu" aria-labelledby="nav-menu-preop">    
        <li>
    <a class="dropdown-item" href="./kq1.html">
 <span class="dropdown-text">KQ1 Expanded Preoperative Screening</span></a>
  </li>  
        <li>
    <a class="dropdown-item" href="./kq2.html">
 <span class="dropdown-text">KQ2 Prehabilitation</span></a>
  </li>  
    </ul>
  </li>
  <li class="nav-item dropdown ">
    <a class="nav-link dropdown-toggle" href="#" id="nav-menu-periop" role="button" data-bs-toggle="dropdown" aria-expanded="false">
 <span class="menu-text">Periop</span>
    </a>
    <ul class="dropdown-menu" aria-labelledby="nav-menu-periop">    
        <li>
    <a class="dropdown-item" href="./kq5.html">
 <span class="dropdown-text">KQ5 Potentially Inappropriate Medications</span></a>
  </li>  
    </ul>
  </li>
  <li class="nav-item dropdown ">
    <a class="nav-link dropdown-toggle" href="#" id="nav-menu-appendix" role="button" data-bs-toggle="dropdown" aria-expanded="false">
 <span class="menu-text">Appendix</span>
    </a>
    <ul class="dropdown-menu" aria-labelledby="nav-menu-appendix">    
        <li>
    <a class="dropdown-item" href="./evidence_tables.html">
 <span class="dropdown-text">Study-level evidence tables</span></a>
  </li>  
    </ul>
  </li>
  <li class="nav-item">
    <a class="nav-link" href="./about.html">
 <span class="menu-text">About</span></a>
  </li>  
</ul>
              <div id="quarto-search" class="" title="Search"></div>
          </div> <!-- /navcollapse -->
      </div> <!-- /container-fluid -->
    </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article page-navbar">
<!-- sidebar -->
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">On this page</h2>
   
  <ul>
  <li><a href="#references" id="toc-references" class="nav-link active" data-scroll-target="#references">References</a></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title">Evidence Tables</h1>
</div>



<div class="quarto-title-meta">

    
  
    
  </div>
  

</header>

<!-- setup -------------------------------------------- (2022-12-24 16:56) @ --->
<div class="cell">

</div>
<div class="cell">
<div class="cell-output-display">

<div id="ykrdqoknin" style="padding-left:0px;padding-right:0px;padding-top:10px;padding-bottom:10px;overflow-x:auto;overflow-y:auto;width:auto;height:auto;">
<style>html {
  font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Helvetica Neue', 'Fira Sans', 'Droid Sans', Arial, sans-serif;
}

:where(#ykrdqoknin) .gt_table {
  display: table;
  border-collapse: collapse;
  margin-left: auto;
  margin-right: auto;
  color: #333333;
  font-size: 16px;
  font-weight: normal;
  font-style: normal;
  background-color: #FFFFFF;
  width: auto;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #A8A8A8;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #A8A8A8;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
}

:where(#ykrdqoknin) .gt_heading {
  background-color: #FFFFFF;
  text-align: center;
  border-bottom-color: #FFFFFF;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

:where(#ykrdqoknin) .gt_caption {
  padding-top: 4px;
  padding-bottom: 4px;
}

:where(#ykrdqoknin) .gt_title {
  color: #333333;
  font-size: 125%;
  font-weight: initial;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-color: #FFFFFF;
  border-bottom-width: 0;
}

:where(#ykrdqoknin) .gt_subtitle {
  color: #333333;
  font-size: 85%;
  font-weight: initial;
  padding-top: 0;
  padding-bottom: 6px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-color: #FFFFFF;
  border-top-width: 0;
}

:where(#ykrdqoknin) .gt_bottom_border {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

:where(#ykrdqoknin) .gt_col_headings {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

:where(#ykrdqoknin) .gt_col_heading {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 6px;
  padding-left: 5px;
  padding-right: 5px;
  overflow-x: hidden;
}

:where(#ykrdqoknin) .gt_column_spanner_outer {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  padding-top: 0;
  padding-bottom: 0;
  padding-left: 4px;
  padding-right: 4px;
}

:where(#ykrdqoknin) .gt_column_spanner_outer:first-child {
  padding-left: 0;
}

:where(#ykrdqoknin) .gt_column_spanner_outer:last-child {
  padding-right: 0;
}

:where(#ykrdqoknin) .gt_column_spanner {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 5px;
  overflow-x: hidden;
  display: inline-block;
  width: 100%;
}

:where(#ykrdqoknin) .gt_group_heading {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  text-align: left;
}

:where(#ykrdqoknin) .gt_empty_group_heading {
  padding: 0.5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: middle;
}

:where(#ykrdqoknin) .gt_from_md > :first-child {
  margin-top: 0;
}

:where(#ykrdqoknin) .gt_from_md > :last-child {
  margin-bottom: 0;
}

:where(#ykrdqoknin) .gt_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  margin: 10px;
  border-top-style: solid;
  border-top-width: 1px;
  border-top-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  overflow-x: hidden;
}

:where(#ykrdqoknin) .gt_stub {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
}

:where(#ykrdqoknin) .gt_stub_row_group {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
  vertical-align: top;
}

:where(#ykrdqoknin) .gt_row_group_first td {
  border-top-width: 2px;
}

:where(#ykrdqoknin) .gt_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

:where(#ykrdqoknin) .gt_first_summary_row {
  border-top-style: solid;
  border-top-color: #D3D3D3;
}

:where(#ykrdqoknin) .gt_first_summary_row.thick {
  border-top-width: 2px;
}

:where(#ykrdqoknin) .gt_last_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

:where(#ykrdqoknin) .gt_grand_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

:where(#ykrdqoknin) .gt_first_grand_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-style: double;
  border-top-width: 6px;
  border-top-color: #D3D3D3;
}

:where(#ykrdqoknin) .gt_striped {
  background-color: rgba(128, 128, 128, 0.05);
}

:where(#ykrdqoknin) .gt_table_body {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

:where(#ykrdqoknin) .gt_footnotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

:where(#ykrdqoknin) .gt_footnote {
  margin: 0px;
  font-size: 90%;
  padding-left: 4px;
  padding-right: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

:where(#ykrdqoknin) .gt_sourcenotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

:where(#ykrdqoknin) .gt_sourcenote {
  font-size: 90%;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

:where(#ykrdqoknin) .gt_left {
  text-align: left;
}

:where(#ykrdqoknin) .gt_center {
  text-align: center;
}

:where(#ykrdqoknin) .gt_right {
  text-align: right;
  font-variant-numeric: tabular-nums;
}

:where(#ykrdqoknin) .gt_font_normal {
  font-weight: normal;
}

:where(#ykrdqoknin) .gt_font_bold {
  font-weight: bold;
}

:where(#ykrdqoknin) .gt_font_italic {
  font-style: italic;
}

:where(#ykrdqoknin) .gt_super {
  font-size: 65%;
}

:where(#ykrdqoknin) .gt_footnote_marks {
  font-style: italic;
  font-weight: normal;
  font-size: 75%;
  vertical-align: 0.4em;
}

:where(#ykrdqoknin) .gt_asterisk {
  font-size: 100%;
  vertical-align: 0;
}

:where(#ykrdqoknin) .gt_indent_1 {
  text-indent: 5px;
}

:where(#ykrdqoknin) .gt_indent_2 {
  text-indent: 10px;
}

:where(#ykrdqoknin) .gt_indent_3 {
  text-indent: 15px;
}

:where(#ykrdqoknin) .gt_indent_4 {
  text-indent: 20px;
}

:where(#ykrdqoknin) .gt_indent_5 {
  text-indent: 25px;
}
</style>
<table class="gt_table">
  
  <thead class="gt_col_headings">
    <tr>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1" scope="col" id="study">study</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_right" rowspan="1" colspan="1" scope="col" id="n_enroll">n_enroll</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1" scope="col" id="incl_excl">incl_excl</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1" scope="col" id="results">results</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1" scope="col" id="comment">comment</th>
    </tr>
  </thead>
  <tbody class="gt_table_body">
    <tr class="gt_group_heading_row">
      <th colspan="5" class="gt_group_heading" scope="colgroup" id="Randomized Clinical Trial">Randomized Clinical Trial</th>
    </tr>
    <tr class="gt_row_group_first"><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Aizawa 2002</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">42</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Age 70-86 yrs.Exclude: Liver cirrhosis; liver dysfunction; respiratory disturbance; metal disorder; visual impairment; emergency surgery.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">The incidence of postoperative delirium, measured using DSM-IV criteria, was (35.0%) in the non delirium prevention protocol group and (5.0%) in the delirium prevention protocol group (p = 0.023).</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Dieleman 2012</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">4494</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Age &gt; 18 yrs.Exclude: Emergent or off-pump procedure; life expectancy &lt; 6 mo.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Postoperative delirium was seen in 9.2% dexamethasone group and 11.7% in the placebo group (RR 0.79, 95% CI: 0.66-0.94, p=0.006).</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">Large multicenter clinical trial on dexamethasone. There were two substudies from this trial (Sauer 2014 and Ottens 2014) that focused on delirium and cognitive decline.</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Fukata 2014</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">121</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Patients age &gt;=75 years; elective abdominal surgery under general anesthesia; elective orthopedic surgery under general/spinal anesthesia.Exclude: Emergency surgery; preop NEECHAM &lt;20; periodic dosing with new or switched antipsychotics, antidepressants, hypnotics, or anti-Parkinson agents within 2 wks of surgery; previous treatment with haloperidol for delirium after surgery.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Among patients undergoing abdominal or orthopedic surgery, 25/59  (42%) patients receiving 2.5 mg haloperidol on days 1-3 postoperatively experienced delirium compared with 20/60 (33%) patients receiving no treatment, [adjusted OR (95% CI): 1.30 (0.54-3.17), p=0.558].</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Fukata 2017</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">201</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Patients age &gt;=75 years; elective abdominal surgery under general anesthesia or elective orthopedic surgery under general/spinal anesthesia.Exclude: Emergency surgery; preop NEECHAM &lt;20; use of new antipsychotics, antidepressants, hypnotics, or anti-Parkinson agents 2 wks before surgery.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Among patients undergoing abdominal or orthopedic surgery, patients receiving 5 mg haloperidol (n=99) postoperatively, experienced less delirium on postoperative day 1 compared with patients receiving no treatment (n=100), 3% vs 13%, respectively, p=0.017. Adjusting for age, sex, preoperative cognition, and type of surgery, the risk (OR, 95% CI) of developing severe postoperative delirium in patients receiving haloperidol compared with no treatment was 0.31, 0.13-0.66.</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Glumac 2017</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">169</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Patients age 41-84 years; elective coronary artery bypass graft, heart valve, or combined surgery with or without cardiopulmonary bypass.Exclude: Cerebrovascular incident past 3 yrs; mental illness; visual, hearing, or motor impairment interfering with cognitive assessment; left ventricular ejection fraction &lt;35%; adrenal gland disease requiring steroids &gt;7 days in past yr; alcohol (&gt;50 g/day or &gt;500 g/wk) or substance abuse; MMSE &lt;26; BDI-II &gt;19; preop CRP &gt;5 mg/L; preop WBC &lt;4 or &gt;10 x10(ninth)/L; stroke; additional corticosteroid during study period.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Patients undergoing cardiac surgery who received dexamethasone (n=80) experienced less postoperative cognitive decline compared with patients who received placebo (n=81), RR (95% CI): 0.43 (0.21-0.89). Subgroup analysis by age shows patients &gt;=65 experience less cognitive decline when receiving dexamethasone (RR, 95% CI: 0.22, 0.05-0.94), while no difference is detected among patients &lt;65 (RR, 95% CI: 0.59, 0.26-1.36).</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Glumac 2021</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">169</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Age 41-84 yrs.Exclude: Cerebrovascular incidence 3 years prior; mental illness; visual, hearing, or motor impairment; hx of cardiac or carotid surgery; adrenal gland disease; alcohol or drug abuse; MMSE &lt; 26; Beck Depression score &gt; 19; perioperative stroke.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Postoperative cognitive decline 6 days after surgery (RR 0.510; 95% CI: 0.24 to 1.079, p=0.067) and 4 year after study conducted was lower in dexamethasone group compared to placebo (RR 0.456; 95% CI: 0.192 to 1.100, p=0.068).</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Hakim 2012</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">101</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Age &gt; 65 yrs.Exclude: Hx of neuropsychiatric disorders, alcoholism; intake of psychotropic mediations.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Incidence of postoperative delirium was lower in the risperidone group compared to placebo (13.7% vs 34%, p=0.031) when given post-operatively.</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Hollinger 2021</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">200</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Aged ≥65 years and scheduled for visceral, orthopaedic, vascular, gynaecological, cardiac, or thoracic surgery.Exclude: Delirium at admission; MMSE score &lt; 24; DOS &gt;= 3; dementia; known ICU admission; haloperidol or ketamine intolerance; communication issues; QT interval prolongation; Parkinson's disease; epilepsy; body weight &gt; 100 kg; intake of dopaminergic drugs.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Delirium was seen in 6.4% of patients in the ketamine group, 11.1% with haloperidol, and 9.1 % with placebo (p=0.16).</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">Baden PRIDe Trial was an investigator-initiated, phase IV, two-centre, randomised, placebo-controlled, double-blind clinical trial. The purpose of this study was to identify within a cohort of ICU patients admitted for severe illness those who are at risk of death in the year following the discharge from ICU. Eleven other articles have indexed this trial.</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Hongyu 2019</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">90</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Age 65-80 years; tumor grade I-III; BMI 18.5-23.9; lung cancer.Exclude: Patients with glaucoma, cataract and other eye diseases; patients with central nervous system and psychiatric disorders, linguistically ineffective communication with psychologists; mini-mental state examination (MMSE) scores ≤23 points.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Mean MMSE score in elderly patients given penehyclidine hydrochloride was higher on POD 1 (24.7 vs 23.8; p&lt;0.05) and lower POD 4 compared to controls (16.7 vs 23.5; p&lt;0.001). Postoperative delirium was seen in 10% of PHH patients on POD 1 and 26.7% on POD 4 compared to 13.3% in controls.</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Kalisvaart 2005</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">430</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Patients age &gt;=70 years; acute or elective hip surgery; at intermediate (1-2 risk factors) or high risk (3-4 risk factors) for postop delirium out of following: 1) visual impairment (worse than 20/70 after correction), 2) APACHE II &gt;=16, 3) MMSE &lt;=24, and 4) index of dehydration (blood urea nitrogen/creatinine ratio &gt;=18).Exclude: Delirium at admission; no risk factors for postop delirium; haloperidol allergy history; cholinesterase inhibitor use; parkinsonism; epilepsy; levodopa treatment; inability to participate in interviews (profound dementia, language barrier, intubation, respiratory isolation, aphasia, coma, terminal illness); surgery delay &gt;72 h after admission; prolonged QTc interval &gt;460 ms (males) or &gt;470 ms (females).</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Delirium incidence was 15.1% (32/212) among patients receiving haloperidol (1.5 mg daily from admission to 3 days postop) and 16.5% (36/218) among patients receiving placebo, (RR, 95% CI: 0.91, 0.59-1.44). Delirium severity (Delirium Rating Scale mean difference, 4.0 [95% CI: 2.0-5.8]) and delirium duration (mean difference in days, 6.4 [95% CI: 4.0-8.0]) were lower in the haloperidol group compared with the placebo group.</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Larsen 2010</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">495</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Age &lt;65 with with a history of post op delirium; age&gt;=65, elective TKR or THR.Exclude: Diagnosis of dementia; active alcohol use; history of alcohol abuse; allergy olanzapine; current use of antipsychotic.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">The incidence of delirium was significantly lower in the olanzapine group than in the placebo group (14.3% vs 40.2%, Adjusted OR:0.2, CI: 0.1-0.4, p&lt;0.001). However, delirium lasted longer in the olanzapine group (2.2 [SD1.3] versus 1.6 [SD0.7] days; p=0.02). The severity of delirium was also greater in the olanzapine-treated group than in the placebo group (16.44 [SD: 3.7] vs 14.5 [SD: 2.7]; p=0.02).</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">High dropout rate, patients stratified by complexity of surgery</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Li 2019</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">164</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Patients age &gt;=65; ASA I-III; elective unilateral total hip replacement or total knee replacement.Exclude: Contraindications to spinal surgery (eg, aortic stenosis, coagulopathy, anticoagulant use, spinal cord disease, refusal of spinal anesthesia); severe hepatic or renal insufficiency; stroke or transient ischemic attack in 1 month; difficulty with neuropsychological assessment (&lt;9 yr education or existing mental disorder).</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Among patients undergoing THA or TKA with spinal anesthesia, patients receiving propofol experienced less postoperative cognitive dysfunction at day 7 compared with patients receiving dexmedetomidine and midazolam, 10/55 (18%) vs 22/55 (40%) vs 28/54 (52%), respectively. No differences in cognitive dysfunction were detected between the groups at 1 yr follow-up.</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Mansouri 2019</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">150</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: &gt; 65 years of age; ASA I and II characteristics; No history of sensitivity to anesthetics; No history of moderate to severe mental disorders;.Exclude: Occurrence of severe hemodynamic disorder during the surgery leading to a change in anesthesia; extended surgery duration for &gt;1 hour; Sensitivity to the anesthetics.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">No statistically significant difference between the midazolam and dexmedetomidine groups in the MMSE score 24 hours after surgery (14% vs 12%, respectively) and 1 week postop (8% vs 12%, respectively; P &gt; 0.05). However, there was a significant difference between these two groups and the control  (8% for Midazolam, 12% for Dexmedetomidine vs 20% Control; P &lt; 0.05).</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Mardani 2013</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">110</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Did not specify.Exclude: Illiteracy; prolonged intubation; &gt;3hrs of CPB; &gt;80 yrs; EF lower than 20% hemodynamic instability; hx of delirium; Emergency Operation; &gt;24hr intubation postoperatively.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Delirium and hospital length of stay significantly decreased in the dexamethasone group compared to the placebo in the first postoperative day (4(9.3%) vs. 13 (26%), p=0.03; 12.93 ± 1.03 vs 13.64 ± 1.75 days, p=0.02, respectively).</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Ottens 2014</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">291</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Age &gt; 18 yrs;.Exclude: Vision impairments; hearing or motor impairment; mental illness.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">At 1-month follow-up, 13.6% in the dexamethasone group 7.2% in the placebo group were diagnosed with POCD (relative risk, 1.87; 95% CI, 0.90 to 3.88; P = 0.09). At 12-month follow-up, 7.0% in the dexamethasone group and 3.5% in the placebo group had POCD (relative risk, 1.98; 95% CI, 0.61 to 6.40; P = 0.24).</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Royse 2017</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">555</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Enrolled in SIRS (Whitlock 2015): age &gt;=18 years; EuroSCORE &gt;=6; cardiac surgery requiring cardiopulmonary bypass.Exclude: Known cognitive impairment or psychiatric illness; (from Whitlock 2015: taking or expected to take steroids immediately postop; bacterial or fungal infection preceding 30 days; steroid intolerance or allergy; expected to receive aprotonin).</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">In a substudy of patients undergoing cardiac surgery requiring cardiopulmonary bypass, a difference was not detected in overall recovery at 6 months in patients receiving methylprednisolone compared with patients receiving placebo, odds ratios over time 039 to 1.45 (95% CI, 0.08-2.04 to 0.40-5.27). Differences were not detected in the subcategories of the recovery scale (cognitive, anxiety and depression, activities of daily living) between the study groups.</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Šakić 2015</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">60</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Elderly patients with well-defined fracture femur for surgical procedure in spinal anesthesia (they never define the age criteria).Exclude: Diagnosis of diabetes mellitus, diagnosis of an autoimmune disease, corticosteroid and immunosuppressive use.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Dexamethasone group had less patients develop postoperative cognitive impairment compared to the levobupivacaine group, (17% vs 72%, respectively).</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Sauer 2014</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">737</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Age &gt;18 yrs; undergoing cardiopulmonary bypass.Exclude: Emergency surgery; scheduled for an off-pump technique; patients with a life expectancy of &lt;6months.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">The intraoperative admin of dexamethasone did not reduce the incidence or duration of delirium in the first 4 days after cardiac surgery.</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">A substudy of DECS trial</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Sultan 2010</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">222</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Age &gt; 65 yrs; ASA I-III.Exclude: Dementia; alcohol abuse; blind/deaf; severe infection; severe anemia; stroke; fluid or electrolyte imbalance; acute cardiac event; acute pulmonary events; on anticonvulsants, antidepressants, antihistamines, antiparkinsonians, antipsychotics, benzodiazepines.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Postoperative delirium was seen in 9.4% of patients given melatonin compared to 32.6% in the control group. This study also compared patients given midazolam (44%) and clonidine (37.2%) preoperatively.</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Tan 2022</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">99</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Age &gt;60; undergoing upper GI endoscopy; ASA I-II.Exclude: Clinically significant cardiorespiratory instability; clinically significant renal or hepatic dysfunction; history of drug/alcohol abuse, neurological disease, auditory, or visual disturbances; pre-existing memory or cognitive impairment; and allergy to anesthetics.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">The addition of 0.1 mg/kg of Remimazolam tosilate as an adjunct to opiate sedation not only achieves more stable perioperative hemodynamics, but also achieves acceptable neuropsychiatric function in elderly patients.</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Wang 2012</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">457</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Patients age &gt;=65 years; noncardiac surgery admitted to ICU.Exclude: Schizophrenia; epilepsy; parkinsonism; cholinesterase inhibitor use; levodopa treatment; inability to communicate (coma, profound dementia, language barrier); haloperidol or other neuroleptic use during or after anesthesia; neurosurgery; unlikely survival &gt;24 hrs; prolonged corrected QT &gt;=460 for men or &gt;=470 for women at baseline.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Among patients undergoing non-cardiac surgery, 35/229  (15%) patients receiving 5 mg haloperidol IV over 12 h postoperatively experienced delirium during the first 7 days post-surgery compared with 53/228 (23%) patients receiving no treatment (p=0.031). A difference was not detected in 28-day mortality between the haloperidol group (0.9%) and the control group (2.6%), p=0.175.</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Wang 2020</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">44</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Currently using a nasal tracheal duct in ICU postop; required sedative treatment; age &gt;= 18; ASA I or II.Exclude: Dx liver dysfunction; dx of kidney dysfunction; ALT exceeding 3x the upper limit of normal as indicator of liver damage; Serum creatinine and urea nitrogen exceeding the upper limit of normal as indicator of impaired renal function; acute myocardial infarction or severe heart failure; drug dependence; alcoholism' hx of psychological illness; severe cognitive dysfunction; currently pregnant or lactating; allergic to midazolam; allergic to dexmedetomidine.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">The incidence of delirium in the dexmedetomidine group was significantly lower than in the midazolam group (1 (1.5%) vs 9 (45%), respectively; P=0.003).</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">Authors were emailed to inquire what scale was used to measure delirium.</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Whitlock 2015</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">7507</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Age &gt;=18; EuroSCORE &gt;=6 (Jul 2011, China and India included EuroSCORE&gt;=4); cardiac surgery requiring cardiopulmonary bypass.Exclude:  Not specified.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Differences were not detected in 30-day mortality between patients receiving methylprednisolone (154/3755, 4%) compared with patients receiving placebo (177/3752, 5%), (RR, 95% CI: 0.87, 0.70-1.07). Differences were not detected in delirium by day 3 between patients receiving methylprednisolone (295/3755, 8%) compared with patients receiving placebo (289/3752, 8%), (RR, 95% CI: 1.02, 0.87-1.19).</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Xiang 2022</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">174</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Age 65-80 years; ASA II-III.Exclude: Dementia; unstable mental status or illness; hx of stroke; hx of gastric ulcer.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Compared with placebo, methylprednisolone greatly reduced the incidence of delirium at 72 hours following surgery (9 [10.7%] vs 20 [23.8%], p = .03, OR = 2.22 [95% CI 1.05–4.59]).</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Yu 2017</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">92</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Age &gt;60 yrs; ASA I-II.Exclude: Senile dementia; coronary heart disease; hypertension; severe hepatic and renal dysfunction; other disease.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Postoperative delirium occurrence rate of 6.52% in dexmedetomidine group was significantly lower than that in the control group, and the difference between the two groups had statistical significance (p &lt;0.05).</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Zhou 2019</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">180</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Patients age &gt;70 years; ASA status I-II; hip arthroplasty surgery.Exclude: History of gastric ulcer or duodenal ulcer; flurbiprofen allergy; severe hepatic or renal disorders; ischemic heart disease; general or local infections.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">Among patients undergoing hip arthroplasty surgery, patients receiving 50 mg flurbiprofen preoperatively (n=60) experienced higher MMSE scores compared with patients receiving nothing (n=60, p&lt;0.01) and patients receiving 50 mg flurbiprofen intraoperatively (n=60, p&lt;0.05) at 3, 12, and 24 h postsurgery. Patients receiving flurbiprofen intraoperatively experienced higher MMSE scores compared to patients receiving nothing, p&lt;0.05.</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Randomized Clinical Trial  study" class="gt_row gt_left">Zhu 2018</td>
<td headers="Randomized Clinical Trial  n_enroll" class="gt_row gt_right">178</td>
<td headers="Randomized Clinical Trial  incl_excl" class="gt_row gt_left">Include: Patients age 65-75 years; elective total knee arthroplasty under general anesthesia.Exclude: MMSE &lt;23; peptic ulcer disease; cardiac-cerebral vascular disease; chronic obstructive pulmonary disease; neurological or psychiatric disorders; NSAIDS allergy; drug or alcohol abuse; hepatic and/or kidney dysfunction; BMI &gt;35; inability to communicate.</td>
<td headers="Randomized Clinical Trial  results" class="gt_row gt_left">In patients undergoing total knee arthroplasty, at 7 days follow-up, 10/81 (12.3%) patients receiving celecoxib (200 mg, twice daily, 7 days preop) experienced postoperative cognitive dysfunction compared with 28/82 (34.1%) patients receiving placebo.</td>
<td headers="Randomized Clinical Trial  comment" class="gt_row gt_left">NA</td></tr>
    <tr class="gt_group_heading_row">
      <th colspan="5" class="gt_group_heading" scope="colgroup" id="Before-After/Time Series">Before-After/Time Series</th>
    </tr>
    <tr class="gt_row_group_first"><td headers="Before-After/Time Series  study" class="gt_row gt_left">Ushida 2009</td>
<td headers="Before-After/Time Series  n_enroll" class="gt_row gt_right">122</td>
<td headers="Before-After/Time Series  incl_excl" class="gt_row gt_left">Include: Patients age &gt;50 years; cervical decompression surgery.Exclude: Pre-existence of dementia or other psychological disorder.</td>
<td headers="Before-After/Time Series  results" class="gt_row gt_left">Patients undergoing cervical decompression surgery following a change in protocol (reduction in methylprednisolone dose and encouragement of free body movement) experienced lower incidence of postoperative delirium compared with patients prior to protocol changes [3/41 (7%) vs 23/81 (28%), p=0.009].</td>
<td headers="Before-After/Time Series  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Before-After/Time Series  study" class="gt_row gt_left">Yamasaki 2019</td>
<td headers="Before-After/Time Series  n_enroll" class="gt_row gt_right">21</td>
<td headers="Before-After/Time Series  incl_excl" class="gt_row gt_left">Include: Patients age &gt;=65 years; hepatectomy.Exclude: Laparoscopic hepatectomy; ICU admission following hepatectomy.</td>
<td headers="Before-After/Time Series  results" class="gt_row gt_left">In patients undergoing hepatectomy, patients receiving omeprazole experienced less postoperative delirium compared with patients receiving famotidine, 3/11 ((27%) vs 9/10 (90%), p&lt;0.01.</td>
<td headers="Before-After/Time Series  comment" class="gt_row gt_left">NA</td></tr>
    <tr class="gt_group_heading_row">
      <th colspan="5" class="gt_group_heading" scope="colgroup" id="Prospective Cohort">Prospective Cohort</th>
    </tr>
    <tr class="gt_row_group_first"><td headers="Prospective Cohort  study" class="gt_row gt_left">Bickel 2008</td>
<td headers="Prospective Cohort  n_enroll" class="gt_row gt_right">200</td>
<td headers="Prospective Cohort  incl_excl" class="gt_row gt_left">Include: Age &gt; 60 yrs.Exclude: Dementia; diagnosis of terminal illness.</td>
<td headers="Prospective Cohort  results" class="gt_row gt_left">Delirium occurred in 24.4% of patients who used psychotropic drugs preoperatively.</td>
<td headers="Prospective Cohort  comment" class="gt_row gt_left">Delirium risk factor from a prospective cohort study of patients undergoing hip surgery. The fully adjusted OR for cognitive impairment among patients with delirium in comparison with the controls without delirium amounted to 4.6 (0.9–42.2) after 8 months and rose to 41.2 (4.3–396.2) after 38 months. Among the 41 patients with delirium a significantly higher proportion (36.6%) died than among the 158 without delirium (10.8%), but after adjustment for confounding variables there remained only a nonsignificant tendency toward an increased mortality risk (1.3 at 8 months vs 1.7 at 38 months).</td></tr>
    <tr><td headers="Prospective Cohort  study" class="gt_row gt_left">Duprey 2022</td>
<td headers="Prospective Cohort  n_enroll" class="gt_row gt_right">566</td>
<td headers="Prospective Cohort  incl_excl" class="gt_row gt_left">Include: Age 70 years or older English speaking (English need not be first language) Scheduled for eligible high-risk surgery: Orthopedic (total hip or knee replacement; lumbar, cervical, or sacral laminectomy)
Vascular (lower extremity arterial bypass surgery; open abdominal aortic aneurysm repair;
lower extremity amputation)
General (open or laparoscopic colectomy)
Planned general or regional anesthesia Scheduled at least 6 days before surgery to allow adequate time for the baseline assessment Planned admission to the hospital for at least 2 days Living within 40 miles from study hospitals Exclusion criteria
Active delirium.Exclude: Active delirium Dementia (dementia diagnosis or score &lt;69 or education-adjusted equivalent on baseline 3MS
cognitive test)
Hospitalization within 3 months before enrollment to minimize risk of recent delirium Terminal condition with life expectancy &lt; 6 months (eg, metastatic cancer, pancreatic cancer,
or receiving palliative care)
Inability to perform cognitive tests because of legal blindness or severe deafness.</td>
<td headers="Prospective Cohort  results" class="gt_row gt_left">134 (24%) developed delirium during hospitalization. 

Preoperative medication associations with delirium: 
benzodiazepines (RR, 1.44; 95% CI, 0.85–2.44)
beta-blocker (RR, 1.38; 95% CI, 0.94–2.05)
NSAID (RR, 1.12; 95% CI, 0.77–1.62)
opioid (RR, 1.22; 95% CI, 0.82–1.82) 
statin (RR, 1.34; 95% CI, 0.92–1.95)

Postoperative medication associations with delirium (before delirium): 
benzodiazepine (aHR, 3.23; 95% CI, 2.10–4.99)
antipsychotic (aHR, 1.48; 95% CI, 0.74–2.94) 
opioid (aHR, 0.82; 95% CI, 0.62–1.11) 

Antipsychotic use (either presurgery or postsurgery) was associated with a 0.34 point (standard error, 0.16) decrease in general cognitive performance at 1 month through its effect on delirium (P = .03), despite no total effect being observed.</td>
<td headers="Prospective Cohort  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Prospective Cohort  study" class="gt_row gt_left">Wang 2021</td>
<td headers="Prospective Cohort  n_enroll" class="gt_row gt_right">1266</td>
<td headers="Prospective Cohort  incl_excl" class="gt_row gt_left">Include: Age 65-85 years, English fluency.Exclude: Brain or cardiac surgery, no written consent.</td>
<td headers="Prospective Cohort  results" class="gt_row gt_left">Premedication using midazolam was not associated with higher incidence of delirium (23%) on the first postoperative day in older patients undergoing major noncardiac surgery compared to no midozolam (25%; OR = 0.91; 95% CI, 0.65-1.29; p=0.67).</td>
<td headers="Prospective Cohort  comment" class="gt_row gt_left">NA</td></tr>
    <tr class="gt_group_heading_row">
      <th colspan="5" class="gt_group_heading" scope="colgroup" id="Retrospective Cohort">Retrospective Cohort</th>
    </tr>
    <tr class="gt_row_group_first"><td headers="Retrospective Cohort  study" class="gt_row gt_left">Jeong 2016</td>
<td headers="Retrospective Cohort  n_enroll" class="gt_row gt_right">527</td>
<td headers="Retrospective Cohort  incl_excl" class="gt_row gt_left">Include: Age &gt;=65 yrs.Exclude: Refused surgery, did not have cancer.</td>
<td headers="Retrospective Cohort  results" class="gt_row gt_left">8.5 % of patients given delirium-inducing medication were diagnosed with postoperative delirium compared to 0.7% of patients without the medication.</td>
<td headers="Retrospective Cohort  comment" class="gt_row gt_left">NA</td></tr>
    <tr><td headers="Retrospective Cohort  study" class="gt_row gt_left">Mangusan 2015</td>
<td headers="Retrospective Cohort  n_enroll" class="gt_row gt_right">656</td>
<td headers="Retrospective Cohort  incl_excl" class="gt_row gt_left">Include: Not specified.Exclude:  Not specified.</td>
<td headers="Retrospective Cohort  results" class="gt_row gt_left">Postoperative delirium occurred in 31% patients who took oral benzodiazepines after cardiac surgery and in 19.8% of patients taking Ketorolac.</td>
<td headers="Retrospective Cohort  comment" class="gt_row gt_left">NA</td></tr>
    <tr class="gt_group_heading_row">
      <th colspan="5" class="gt_group_heading" scope="colgroup" id="Case-Control">Case-Control</th>
    </tr>
    <tr class="gt_row_group_first"><td headers="Case-Control  study" class="gt_row gt_left">Choi 2019</td>
<td headers="Case-Control  n_enroll" class="gt_row gt_right">58</td>
<td headers="Case-Control  incl_excl" class="gt_row gt_left">Include: Patients with postoperative acute lung injury after lung resection surgery for lung cancer.Exclude: Respiratory distress due to respiratory/systemic infection.</td>
<td headers="Case-Control  results" class="gt_row gt_left">In a case-control study of patients developing acute lung injury after lung resection surgery, patients administered corticosteroids early (within 72 h) experienced less postoperative delirium compared with patients receiving corticosteroids later  (after 72 h), 10/42 (24%) vs 10/16 (63%), p=0.012. Differences were not detected between the groups in complications or length of stay.</td>
<td headers="Case-Control  comment" class="gt_row gt_left">Patients receiving early treatment with corticosteroids had greater improvements in lung injury score (primary outcome) compared with patients receiving later treatment; however, no difference was detected in mechanical ventilation weaning within 7 days (primary outcome).</td></tr>
    <tr><td headers="Case-Control  study" class="gt_row gt_left">Nandi 2014</td>
<td headers="Case-Control  n_enroll" class="gt_row gt_right">463</td>
<td headers="Case-Control  incl_excl" class="gt_row gt_left">Include: Patients undergoing primary or revision total hip or knee arthroplasty under general anesthesia.Exclude: Spinal anesthesia; antipsychotic drug use.</td>
<td headers="Case-Control  results" class="gt_row gt_left">A case-control study of patients undergoing THA or TKA, reported an increased risk of postoperative delirium among patients administered benzodiazepines during hospital stay compared with patients not receiving benzodiazepines [adjusted OR (95% CI): 9.68 (4.30-21.79)].</td>
<td headers="Case-Control  comment" class="gt_row gt_left">OR adjusted for sex, preop alcohol use, and preop depression.</td></tr>
  </tbody>
  
  
</table>
</div>
</div>
</div>
<section id="references" class="level1">
<h1>References</h1>


</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    target: function(trigger) {
      return trigger.previousElementSibling;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
</div> <!-- /content -->



</body></html>